NiveshIQ
Senores Pharmaceuticals Ltd.
NiveshIQ has detected 5 active signals on SENORES. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Senores Pharmaceuticals Ltd.
Senores Pharmaceuticals Limited, founded in 2017 and headquartered in Ahmedabad, focuses on developing, manufacturing, and selling a broad portfolio of pharmaceutical products across India, the United States, the United Kingdom, and Canada. Its core revenue drivers include analgesic/antipyretic, antibacterial/antibiotic, antiviral, and antifungal products, alongside specialty segments such as cardiovascular and neurology formulations. In FY2023, the company generated ₹680 crore in revenue and ₹127 crore in net income, reflecting a healthy profit margin of approximately 18.7%. Recent developments include expanding its international distribution network and securing new contracts for generic drug supply in the U.S. market. Competitively, Senores leverages its diversified product mix and cost
Financial Highlights
| Metric | FY26 |
|---|---|
| Revenue | ₹614.18 Cr +61.40% |
| EBITDA Margin | 34.88% |
| Net Profit | ₹115.38 Cr +97.00% |
| EPS | ₹26.39 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Strategic Outlook
- Q1FY27 results: revenue ₹180 Cr, PAT ₹31 Cr, EPS ₹6.61, EBITDA margin 31.4%. Growth context: revenue YoY +35.9%, PAT YoY +55.7%, revenue QoQ +2.9%, PAT QoQ -2.8%.
Product pipeline delivery, domestic demand, export mix, approvals, and margin discipline remain the key forward drivers ...
FY26 (last completed FY): revenue ₹614 Cr, PAT ₹115 Cr, EBITDA margin 34.9%, EPS ₹26.39. Year-on-year: revenue YoY +61.4...
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Senores Pharmaceuticals Ltd.?
NiveshIQ detects active intelligence signals for Senores Pharmaceuticals Ltd. (SENORES) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Senores Pharmaceuticals Ltd.?
Senores Pharmaceuticals Ltd. operates in the Healthcare sector with a market capitalisation of ₹621,539.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.